TransCode Therapeutics, Inc. (RNAZ)
1.51
-0.09
(-5.62%)
USD |
NASDAQ |
Nov 05, 16:00
TransCode Therapeutics Price : 1.51 for Nov. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 1.63 | 1.67 | 1.475 | 1.51 | 21851.00 |
| Nov 04, 2026 | 1.61 | 1.720 | 1.57 | 1.60 | 7099.00 |
| Nov 03, 2026 | 1.60 | 1.65 | 1.50 | 1.57 | 29550.00 |
| Nov 02, 2026 | 1.69 | 1.69 | 1.61 | 1.63 | 16520.00 |
| Oct 30, 2026 | 1.73 | 1.785 | 1.62 | 1.63 | 16185.00 |
| Oct 29, 2026 | 1.837 | 1.91 | 1.73 | 1.73 | 40837.00 |
| Oct 28, 2026 | 1.61 | 1.78 | 1.61 | 1.74 | 18494.00 |
| Oct 27, 2026 | 1.71 | 1.770 | 1.65 | 1.67 | 7503.00 |
| Oct 26, 2026 | 1.78 | 1.78 | 1.70 | 1.706 | 54291.00 |
| Oct 23, 2026 | 1.65 | 1.84 | 1.65 | 1.77 | 32683.00 |
| Oct 22, 2026 | 1.62 | 1.80 | 1.62 | 1.715 | 27966.00 |
| Oct 21, 2026 | 1.69 | 1.810 | 1.65 | 1.66 | 16753.00 |
| Oct 20, 2026 | 1.71 | 1.75 | 1.602 | 1.68 | 20230.00 |
| Oct 19, 2026 | 1.70 | 1.840 | 1.66 | 1.70 | 29305.00 |
| Oct 16, 2026 | 1.83 | 1.864 | 1.695 | 1.70 | 29017.00 |
| Oct 15, 2026 | 1.790 | 1.900 | 1.71 | 1.80 | 35314.00 |
| Oct 14, 2026 | 1.74 | 1.82 | 1.67 | 1.73 | 43236.00 |
| Oct 13, 2026 | 1.67 | 1.780 | 1.668 | 1.68 | 54452.00 |
| Oct 12, 2026 | 1.91 | 1.91 | 1.63 | 1.63 | 31932.00 |
| Oct 09, 2026 | 1.78 | 1.95 | 1.74 | 1.86 | 84076.00 |
| Oct 08, 2026 | 1.80 | 1.80 | 1.675 | 1.71 | 27836.00 |
| Oct 07, 2026 | 1.78 | 1.79 | 1.67 | 1.76 | 29763.00 |
| Oct 06, 2026 | 1.77 | 1.815 | 1.71 | 1.78 | 47336.00 |
| Oct 05, 2026 | 1.65 | 1.87 | 1.57 | 1.76 | 65725.00 |
| Oct 02, 2026 | 1.58 | 1.66 | 1.545 | 1.57 | 15503.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 57.83 |
| Oncolytics Biotech, Inc. | 0.4545 |
| Sangamo Therapeutics, Inc. | 0.114 |
| Sarepta Therapeutics, Inc. | 17.67 |
| Anixa Biosciences, Inc. | 3.02 |
Price Related Metrics
| Earnings Yield | -3.36K% |
| Market Cap | 1.528M |